2022 annual financial data
TransCode Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -18,665,814 USD and net income was -17,564,968 USD.
Operating cash flow was -15,762,512 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,665,814 USD
- Net income
- -17,564,968 USD
- Operating cash flow
- -15,762,512 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all TransCode Therapeutics financial years